Medical Weight Loss Treatment for Indiana Residents
Medically Supervised Weight Loss, Delivered Online
Our medical providers are licensed by the Indiana Professional Licensing Agency for comprehensive telehealth services statewide.
Whether you're in Indianapolis, Indianapolis, or anywhere across Indiana — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Indiana
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
From the racing culture of Indianapolis to the manufacturing heritage of Fort Wayne, Hoosiers work hard and deserve healthcare that works for them. OmniRx Health brings specialized telemedicine to Indiana—serving the young professionals of downtown Indy, the families in suburban Hamilton County, the students at Purdue and IU, and the agricultural communities that feed the nation. No more taking half a day off work just for a doctor's appointment.
Available Treatments in Indiana
Our board-certified providers in Indiana can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Indiana
State Licensing
Our medical providers are licensed by the Indiana Professional Licensing Agency for comprehensive telehealth services statewide.
Telehealth Law
Indiana's telehealth regulations support provider practice while ensuring patient safety standards are met for virtual care delivery.
Pharmacy Access
Indiana pharmacies in Indianapolis, Fort Wayne, South Bend, and throughout the state ensure quick prescription fulfillment and delivery.
Insurance Notes
Indiana insurers provide telehealth coverage, with ongoing improvements to ensure virtual care is accessible and affordable for Hoosiers.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Indiana
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.